The Understanding (tumour-host interactions) Cluster has published a joint press release summarising the main conclusions of its first annual meeting. The document highlights progress in collaborative research, data management, patient engagement and policy development, contributing to the objectives of the EU Cancer Mission.
Download the full press release on our materials page to learn more about the cluster’s priorities and planned actions.
The KU Leuven team attended EANO 2026 in Rome and Chiara Caprioli and Frederik De Smet presented glioblastoma research and a patient-derived brain tumour model. Discover highlights from the conference.
At the SIOPE Brain Tumour Group Annual Meeting 2026, KU Leuven researcher Julie Morscio discussed how patient-derived tumour models can help investigate why diffuse midline glioma cells survive radiotherapy. Read her testimonial.
In this GLIOMATCH: Explained episode, Dr. Chiara Caprioli and Prof. Frederik De Smet from KU Leuven explain how new research has mapped the evolution of glioblastoma from diagnosis to recurrence, identified distinct tumour trajectories and established a framework that could support more personalised treatment decisions.
In this GLIOMATCH: Explained episode, Prof. Dr. Sandra Jacobs introduces the paediatric clinical study, the participating centres and the challenges of working with archived samples from paediatric high-grade glioma patients.
